Sign in

CIK 0001576280 · Large accelerated filer

Guardant Health, Inc.

Sign in to watch
Ticker
GH
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
454139254
Phone
855-698-8887
Business address
3100 HANOVER STREET, PALO ALTO, CA, 94304
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$9,739,100
in 9 filings, $213K under 10b5-1 plans

Net −$9,739,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Talasaz AmirAli −$6.3M Co-Chief Executive Officer sold 50% of stake
  2. Chudova Darya −$1.4M Chief Technology Officer sold 10% of stake
  3. Krognes Steve E. −$1.2M Director sold 46% of stake
  4. Kalia Kumud −$632K Chief Information Officer sold 9% of stake
  5. Azar Alex M II −$156K Director sold 50% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 Azar Alex M II Director Option exercise +138 1,031
2026-11-12 Azar Alex M II Director Option exercise · Restricted Stock Units −138 4,678
2026-10-14 Azar Alex M II Director Sale 10b5-1 −69 $159.89 $11K 893
2026-10-12 Azar Alex M II Director Option exercise +137 962
2026-10-12 Azar Alex M II Director Option exercise · Restricted Stock Units −137 4,816
2026-09-16 Azar Alex M II Director Sale 10b5-1 −826 $175.00 $145K 825
2026-09-12 Azar Alex M II Director Option exercise +1,651 1,651
2026-09-12 Azar Alex M II Director Option exercise · Restricted Stock Units −1,651 4,953
2026-06-17 Azar Alex M II Director Grant or award · Restricted Stock Units +2,711 2,711

Page 1 of 1 · 9 trades